Management of non-traumatic intraventricular hemorrhage
- 1.4k Downloads
Intraventricular hemorrhage (IVH) is defined as the eruption of blood in the cerebral ventricular system and is mostly secondary to spontaneous intracerebral hemorrhage and aneurysmal and arteriovenous malformation rupture. IVH is a proven risk factor of increased mortality and poor functional outcome. Its seriousness is correlated not only with the amount of blood but also with the involvement of the third and fourth ventricles. There are four mechanisms that explain the pathophysiology of this event: acute obstructive hydrocephalus, the mass effect exerted by the blood clot, the toxicity of blood-breaking products on the adjacent brain parenchyma, and, lastly, the development of a chronic hydrocephalus. It is thus obvious that the clearance of blood from the ventricles should be a therapeutic goal. In cases of acute hydrocephalus, external ventricular drainage is a mandatory step, but proven often insufficient. The concomitant use of intraventricular fibrinolytics such as recombinant tissue plasminogen activator or urokinase seems to be beneficial at least in the context of spontaneous intracerebral hemorrhage, in which their use is now accepted but not yet validated by a randomized trial. Given the potential neurotoxicity of these agents, further research is needed in order to identify the best treatment for intraventricular fibrinolysis (IVF). The endoscopic retrieval of intraventricular blood was also described recently and seems to be as efficient as IVF, but its use is limited to specialized centers. IVH represents a therapeutic challenge for neurosurgeons, neurologists, and intensivists. Thus, a better understanding of this dramatic event will help in better tailoring the treatment strategies.
KeywordsIntraventricular Cerebral hemorrhage Fibrinolytic agents Ventriculostomy Neuroendoscopy
The authors thank Miss Apollonia Annang for her assistance in English corrections and Keven Ponte for his computing assistance.
Sources of funding
Conflicts of interest/disclosures
The authors declare that they have no conflict of interest or financial disclosure.
- 1.Almairac F, Litrico S, Fontaine D, Lonjon M, Paquis P (2011) Evaluation of intraventricular thrombolysis for severe intraventricular hemorrhage after aneurysmal rupture: a prospective randomized study. Paper presented at the 4th World ICH conference 2011, World Federation of Neurosurgical Societies and European Associations of Neurosurgery, Newcastle, UK, 3 May 2011Google Scholar
- 2.Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN et al (2011) American Heart Association. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40:994–1025 (review)CrossRefGoogle Scholar
- 3.Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD (2006) Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the stitch trial. Acta Neurochir Suppl 96:65–68Google Scholar
- 6.Cheung RTF, Zou LY (2003) Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage. Stroke 34:1717–1722Google Scholar
- 7.Daverat P, Castel JP, Dartigues JF, Orgogozo JM (1991) Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 22:1–6Google Scholar
- 9.Ducruet AF, Hickman ZL, Zacharia BE, Grobelny BT, Narula R, Guo KH et al (2010) Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage. Neurosurgery 66:648–655PubMedCrossRefGoogle Scholar
- 16.Hallevi H, Albright KC, Aronowski J, Barreto AD, Martin-Schild S, Khaja AM et al (2008) Intraventricular hemorrhage. Anatomic relationships and clinical implications. Neurology 70:848–852Google Scholar
- 17.Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC (2001) The ich score: a simple reliable grading scale for intracerebral hemorrhage. Stroke 32:891–897Google Scholar
- 20.LaPointe M, Haines S (2002) Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD003692. doi: 10.1002/14651858.CD003692
- 26.Marti Fabregas J, Belvis R, Guardia E, Cocho D, Munoz J, Marruecos L et al (2003) Neurology 61:1051–1056Google Scholar
- 31.Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, The American Heart Association Stroke Council and Council on Cardiovascular Nursing et al (2010) Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 41:2108–2129PubMedCrossRefGoogle Scholar
- 35.Nishikawa T, Ueba T, Kajiwara M, Miyamatsu N, Yamashita K (2009) A priority treatment of the intraventricular hemorrhage (IVH) should be performed in the patients suffering intracerebral hemorrhage with large IVH. Clin Neurol Neurosurg 111:450–453Google Scholar
- 44.Razzaq AA, Hussain R (1998) Determinants of 30-day mortality of spontaneous intracerebral hemorrhage in Pakistan. Surg Neurol 50:336–343Google Scholar
- 46.Rohde V, Rohde I, Thiex R, Ince A, Jung A, Dückers G et al (2002) Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg 97:954–962PubMedCrossRefGoogle Scholar
- 53.Takahashi O, Cook EF, Nakamura T, Saito J, Ikawa F, Fukui T (2006) Risk stratification for in-hospital mortality in spontaneous intracerebral hemorrhage: a classification and regression tree analysis. Q J Med 99: 743–750Google Scholar